MedTrace Logo

QT Variability Pre and Post Cardioversion

NCT00885391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2014-12-11

No results posted yet for this study

Summary

The purpose of this study is to learn whether the chemicals in the blood and urine are different when the heart is atrial fibrillation compared to normal sinus rhythm.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Wake Forest University Health Sciences

    collaborator OTHER

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Dawood Darbar, M.D., Ph.D., F.A.C.C. · Vanderbilt University Medical Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885391 on ClinicalTrials.gov